Page 87 - Michael Erman News Today

10 Apr 2021 / 09:00 H. (Adds outside comment, details throughout) By Carl ODonnell April 1 (Reuters) - Pfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset of study volunteers in South Africa, where a concerning new variant called B.1.351 is circulating. Although lower than the stunning 9...

3 Min Read (Reuters) -The U.S. government will allocate nearly 85% fewer Johnson & Johnson COVID-19 vaccine doses to states next week, according to data from the Centers for Disease Control and Prevention (CDC), due to uneven production related in part to problems at a Baltimore manufacturing plant. FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson Allocations will fall to 7...

Pfizer Inc and BioNTech said on Thursday their COVID-19 vaccine is around 91% effective at preventing the disease, after trial of 12,000 participants inoculated for up to six months.

Pfizer Inc and BioNTech's COVID-19 vaccine is around 91% effective at preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months.

Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant By Carl ODonnell Reuters (Reuters) - Pfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset of study volunteers in South Africa, where a concerning new variant called B.1.351 is circulat...

By Carl ODonnell April 1 (Reuters) - Pfizer Inc and BioNTechs COVID-19 vaccine is around 91% effective at preventing the disease, they said on Thursday, citing updated trial data that included participants inoculated for up to six months. The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800. While the new overall efficacy rate of 91.3% is ...

UPDATE 3-Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant Reuters 1 hr ago By Carl ODonnell April 1 (Reuters) - Pfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months. The shot also showed early signs of preventing disease in a small subset of study volunteers in South Africa, where a concerning new variant ca...

15 Min Read BRUSSELS (Reuters) - In a meeting last week in the Europa building in Brussels, home of the European Union’s political leadership, diplomats for the 27 member states were desperate. The EU had paid billions of euros toward shots to curb a pandemic that was killing thousands of Europeans every day. Now vaccine-makers had cut back deliveries, and the EU was trapped in a public fight. “This is a catastrophe,” French ambassador Philippe Leglise-Costa told the Jan. 27 meeting, acco...

Results of AstraZeneca Plc's U.S. COVID-19 vaccine trial are being reviewed by independent monitors, and emergency authorization could come in about a month, a top U.S. official said on Monday.

<div class="at-above-post addthis_tool" data-url="https://www.metro.us/exclusive-u-s-green-light/"></div>CHICAGO (Reuters) – Results of AstraZeneca Plc’s U.S. COVID-19 vaccine trial are being reviewed by independent monitors, and emergency authorization could come in about a month, a top U.S. official said on Monday. The independent monitors are analyzing data from the 32,000-person U.S. study to determine whether the vaccine is safe and effective. If ...